When testing testosterone replacement therapy, the initial response should not be evaluated as a double-blind placebo-controlled trial because placebo effects will be present, so instead clinicians should look for a "hell yes" response, and if the response is equivocal, the treatment should be discontinued and symptoms reassessed to determine if the deficit reappears.

normativepending

Speaker

Unidentified Speaker — Peter Attia on Treating Low Testosterone (and why TRT isn't… [htfbGGeliZU]

Evidence Quote

“if the response we see isn't a hell yes I think we should pull pull it all off and see if we notice a response in the deficit”

Source

Peter Attia on Treating Low Testosterone (and why TRT isn't always the right answer)— FoundMyFitness Clips
Created: 8/12/2026, 6:01:12 PM

Your notes

Loading notes...